CytoAgents
Pittsburgh, PA
CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation also known as cytokine storm.
cytoagents.comCompany Details
Founded
- 2018
Employees
- Between 5 - 20 employees
Raised
- $19,206,500
Headquarters Location
- Pittsburgh, PA
Public
- No
Acquired
- No
CEO
Teresa Whalen
Founders
- Teresa Whalen
Company Collections
These are collections CytoAgents is a part of. Click on the collection name to view similar companies.
CytoAgents' Industries
Company Collections For CytoAgents
CytoAgents Headquarters Location
100 S Commons #102, Pittsburgh, PA 15212
Total Amount Raised: $19,206,500
CytoAgents Funding Rounds
Grant
$2,000,000
Grant Investors
National Institutes of Health (NIH)Series A
$7,000,000
Series A Investors
PCG CapitalBlueTree Allied AngelsSeries Unknown
$6,106,500
Seed
$100,000
Seed Investors
Innovation WorksGrant
$2,000,000
Grant Investors
National Institutes of Health (NIH)Seed
$50,000
Seed Investors
Innovation WorksAlphaLab HealthGrant
$250,000
Grant Investors
Richard King Mellon FoundationGrant
$1,600,000
Grant Investors
National Institutes of Health (NIH)Seed
$100,000
Seed Investors
Innovation Works
Funding info provided by Diffbot.
CytoAgents Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on CytoAgents.